237 related articles for article (PubMed ID: 16111316)
1. [Immunologic tests: Anti-PL 7 antibodies, anti-PL-12 antibodies, and other anti-aminoacyl tRNA synthetase antibodies].
Hirakata M; Katsuki Y; Sato S
Nihon Rinsho; 2005 Jul; 63 Suppl 7():508-11. PubMed ID: 16111316
[No Abstract] [Full Text] [Related]
2. [Anti-PL-7, anti-PL-12, and other anti-aminoacyl tRNA synthetase antibodies].
Hirakata M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():555-9. PubMed ID: 20942128
[No Abstract] [Full Text] [Related]
3. [Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].
Katsuki Y; Hirakata M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():505-7. PubMed ID: 16111315
[No Abstract] [Full Text] [Related]
4. [Anti-Jo-1(histidyl tRNA synthetase) antibodies].
Hirakata M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():551-4. PubMed ID: 20942127
[No Abstract] [Full Text] [Related]
5. [Anti-PL-7 autoantibodies and anti-PL-12 autoantibodies (anti-aminoacyl-tRNA 'other than histidyl' synthetase autoantibodies)].
Hirakata M; Satoh S; Mimori T
Nihon Rinsho; 1999 Nov; 57 Suppl():435-8. PubMed ID: 10635876
[No Abstract] [Full Text] [Related]
6. [Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody].
Abe T; Tsunoda S; Nishioka A; Azuma K; Tsuboi K; Ogita C; Yokoyama Y; Furukawa T; Maruoka M; Tamura M; Yoshikawa T; Saito A; Sekiguchi M; Azuma N; Kitano M; Matsui K; Hosono Y; Nakashima R; Ohmura K; Mimori T; Sano H
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):140-4. PubMed ID: 27212600
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis/polymyositis and interstitial lung disease.
Hane H; Muro Y; Watanabe K; Ogawa Y; Sugiura K; Akiyama M
Clin Chim Acta; 2014 Apr; 431():9-14. PubMed ID: 24508626
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
[TBL] [Abstract][Full Text] [Related]
9. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
[TBL] [Abstract][Full Text] [Related]
10. [Interstitial lung disease in patients with connective tissue diseases].
Hirakata M; Nakamura K; Kaburaki J; Suwa A; Mimori T; Kanazawa M; Akizuki M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():268-76. PubMed ID: 8752518
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic tests: Anti Ki/PA28gamma antibody].
Okano T; Satoh M; Akizuki M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():519-22. PubMed ID: 16111319
[No Abstract] [Full Text] [Related]
12. [Immunologic tests: Anti-polymyositis-scleroderma (PM-Scl) antibody].
Takasaki Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():502-4. PubMed ID: 16111314
[No Abstract] [Full Text] [Related]
13. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.
Nakashima R; Hosono Y; Mimori T
Lupus; 2016 Jul; 25(8):925-33. PubMed ID: 27252271
[TBL] [Abstract][Full Text] [Related]
15. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
Hirakata M; Suwa A; Nagai S; Kron MA; Trieu EP; Mimori T; Akizuki M; Targoff IN
J Immunol; 1999 Feb; 162(4):2315-20. PubMed ID: 9973509
[TBL] [Abstract][Full Text] [Related]
16. Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.
Yamasaki Y; Satoh M; Mizushima M; Okazaki T; Nagafuchi H; Ooka S; Shibata T; Nakano H; Ogawa H; Azuma K; Maeda A; Tonooka K; Ito H; Takakuwa Y; Inoue M; Mitomi H; Kiyokawa T; Tsuchida K; Matsushita H; Mikage H; Murakami Y; Chan JY; Ozaki S; Yamada H
Mod Rheumatol; 2016; 26(3):403-9. PubMed ID: 26344678
[TBL] [Abstract][Full Text] [Related]
17. Distinct clinical and histological features in dermatomyositis with anti-aminoacyl-tRNA synthetase antibodies.
Ishibuchi H; Motegi S; Kishi C; Amano H; Ishikawa O
J Dermatol; 2016 Aug; 43(8):978-80. PubMed ID: 26919552
[No Abstract] [Full Text] [Related]
18. [Anti-Jo-1 antibody and anti-aminoacyl-tRNA synthetase antibody as a marker autoantibody for myositis].
Kinoshita M
Nihon Rinsho; 1990 Feb; 48 Suppl():482-4. PubMed ID: 2355568
[No Abstract] [Full Text] [Related]
19. Antisynthetase syndrome presenting as rheumatoid-like polyarthritis.
Mumm GE; McKown KM; Bell CL
J Clin Rheumatol; 2010 Oct; 16(7):307-12. PubMed ID: 20859229
[TBL] [Abstract][Full Text] [Related]
20. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.
Betteridge Z; Gunawardena H; North J; Slinn J; McHugh N
Rheumatology (Oxford); 2007 Jun; 46(6):1005-8. PubMed ID: 17392287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
